Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (808)
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,300
Price
$100.14
Total Value
$230.32K
Shares Held After
194,309
% of Holdings
1.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,017
Price
$99.25
Total Value
$597.19K
Shares Held After
196,609
% of Holdings
3.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
11,683
Price
$98.51
Total Value
$1.15M
Shares Held After
202,626
% of Holdings
5.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,626
Price
$102.80
Total Value
$167.15K
Shares Held After
40,418
% of Holdings
3.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
397
Price
$111.77
Total Value
$44.37K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
470
Price
$111.05
Total Value
$52.19K
Shares Held After
397
% of Holdings
54.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
272
Price
$109.96
Total Value
$29.91K
Shares Held After
867
% of Holdings
23.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
831
Price
$108.95
Total Value
$90.54K
Shares Held After
1,139
% of Holdings
42.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
737
Price
$108.17
Total Value
$79.72K
Shares Held After
1,970
% of Holdings
27.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
70
Price
$107.11
Total Value
$7.50K
Shares Held After
2,707
% of Holdings
2.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
700
Price
$111.41
Total Value
$77.99K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,000
Price
$110.64
Total Value
$110.64K
Shares Held After
700
% of Holdings
58.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,800
Price
$109.30
Total Value
$196.74K
Shares Held After
1,700
% of Holdings
51.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
2,800
Price
$108.38
Total Value
$303.46K
Shares Held After
3,500
% of Holdings
44.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,450
Price
$107.58
Total Value
$155.99K
Shares Held After
6,300
% of Holdings
18.7%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
16,167
Price
$110.38
Total Value
$1.78M
Shares Held After
0
% of Holdings
100.0%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
390
Price
$14.34
Total Value
$5.59K
Shares Held After
73,488
% of Holdings
0.5%
Lyell Immunopharma, Inc. (LYEL)
Bulis Veronica Sanchez — VP, Corporate Controller
Shares
621
Price
$14.34
Total Value
$8.91K
Shares Held After
14,799
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
214
Price
$538.86
Total Value
$115.32K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
186
Price
$537.91
Total Value
$100.05K
Shares Held After
324,657
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
514
Price
$536.23
Total Value
$275.62K
Shares Held After
324,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
286
Price
$535.27
Total Value
$153.09K
Shares Held After
325,357
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$533.21
Total Value
$208.49K
Shares Held After
325,643
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$532.28
Total Value
$244.32K
Shares Held After
326,034
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$531.15
Total Value
$339.94K
Shares Held After
326,493
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,027
Price
$530.26
Total Value
$1.61M
Shares Held After
327,133
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,050
Price
$529.27
Total Value
$555.73K
Shares Held After
330,160
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
731
Price
$528.40
Total Value
$386.26K
Shares Held After
331,210
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
722
Price
$527.38
Total Value
$380.77K
Shares Held After
331,941
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$525.73
Total Value
$63.09K
Shares Held After
332,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
582
Price
$524.86
Total Value
$305.47K
Shares Held After
332,783
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$523.95
Total Value
$302.84K
Shares Held After
333,365
% of Holdings
0.2%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
131
Price
$14.34
Total Value
$1.88K
Shares Held After
17,677
% of Holdings
0.7%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
89
Price
$14.34
Total Value
$1.28K
Shares Held After
17,805
% of Holdings
0.5%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
92,444
Price
$7.00
Total Value
$647.11K
Shares Held After
2,691,337
% of Holdings
3.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$76.76
Total Value
$575.70K
Shares Held After
377,820
% of Holdings
1.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
616
Price
$111.18
Total Value
$68.49K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
3,217
Price
$110.61
Total Value
$355.83K
Shares Held After
616
% of Holdings
83.9%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
15,248
Price
$26.06
Total Value
$397.36K
Shares Held After
72,416
% of Holdings
17.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Moran Sean F. — Chief Financial Officer
Shares
12,000
Price
$10.08
Total Value
$120.97K
Shares Held After
84,694
% of Holdings
12.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Cohen Yuval — Director
Shares
17,000
Price
$10.08
Total Value
$171.40K
Shares Held After
157,316
% of Holdings
9.8%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
10,000
Price
$104.68
Total Value
$1.05M
Shares Held After
9,360
% of Holdings
51.7%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
8,000
Price
$104.38
Total Value
$835.04K
Shares Held After
19,360
% of Holdings
29.2%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
5,000
Price
$104.47
Total Value
$522.35K
Shares Held After
0
% of Holdings
100.0%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
39,051
Price
$4.06
Total Value
$158.55K
Shares Held After
785,867
% of Holdings
4.7%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
52,317
Price
$6.85
Total Value
$358.37K
Shares Held After
2,783,781
% of Holdings
1.8%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
52,317
Price
$6.85
Total Value
$358.37K
Shares Held After
2,783,781
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$540.32
Total Value
$64.84K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
632
Price
$539.14
Total Value
$340.74K
Shares Held After
324,563
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$538.54
Total Value
$336.59K
Shares Held After
325,195
% of Holdings
0.2%
Showing 1–50 of 808 transactions (page 1 of 17)